FDA & Government News

June 18, 2026

Top 10 FDA Recalls Physicians Should Know

A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

Conexiant

June 17, 2026

Oral Carbapenem Wins FDA Approval for cUTIs

Tebipenem pivoxil was noninferior to intravenous imipenem-cilastatin in hospitalized adults.

Conexiant

June 15, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Conexiant

June 08, 2026

FDA Expands Marstacimab Indication in Hemophilia A and B

Phase 3 BASIS and BASIS KIDS data supported the expanded indication across pediatric and inhibitor-pretreated populations.

Conexiant

June 03, 2026

Hospital AI Fails to Flag Drug Diversion

"I've never myself seen these technologies be called out in that specific way"

Kff Health News

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

May 27, 2026

FDA OKs Linaclotide in Young Children

Phase 3 data expanded use of linaclotide 72 mcg in pediatric functional constipation.

Conexiant

May 21, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

Conexiant

April 23, 2026

FDA Grants Accelerated Approval for OTOF Gene Therapy

A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.

Conexiant

April 16, 2026

When ‘Family Planning’ Shifts Meaning

A program built on prevention now tilts toward population goals, testing the balance between public health and personal choice.

Kff Health News

April 16, 2026

When ‘Family Planning’ Shifts Meaning

A program built on prevention now tilts toward population goals, testing the balance between public health and personal choice.

Kff Health News

Surgeon Sleep Timing Tied to Risk

FDA & Government News

Top 10 FDA Recalls Physicians Should Know

Oral Carbapenem Wins FDA Approval for cUTIs

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

FDA Expands Marstacimab Indication in Hemophilia A and B

Hospital AI Fails to Flag Drug Diversion

Daily News

FDA OKs Linaclotide in Young Children

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

FDA Grants Accelerated Approval for OTOF Gene Therapy

When ‘Family Planning’ Shifts Meaning

When ‘Family Planning’ Shifts Meaning

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

Surgeon Sleep Timing Tied to Risk

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dentistry

ADA News

CDE World

New Dentist News

Conexiant

AACE Endocrinology AI

Conexiant

GI & Hepatology News

The ASCO Post

JADPRO

JNCCN

JNCCN 360

ASCO AI in Oncology

Glaucoma Physician

Ophthalmology Management

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

The Pathologist

FDA & Government News

Daily News

Recommendations